• No results found

Iron-Chelation

Beliefs of Jordanian Children with Thalassemia toward Using Iron Chelation Therapy

Beliefs of Jordanian Children with Thalassemia toward Using Iron Chelation Therapy

... of iron in the vital organs, organ dysfunction, and death. Further, iron overload includes other complications such as growth retardation and failure of sexual maturation ...require iron ...

11

Is Iron Chelation Therapy Useful in Persons with Myelodysplastic Syndrome Receive?

Is Iron Chelation Therapy Useful in Persons with Myelodysplastic Syndrome Receive?

... increased iron absoption associated with ineffective ...hereditary iron-loading anemias indicate long- term consequences of iron toxicity are preventable and potentially reversible by effective ...

5

Cost utility analysis of reduced intensity hematopoietic stem cell transplantation in adolescence and young adult with severe thalassemia compared to hypertransfusion and iron chelation program

Cost utility analysis of reduced intensity hematopoietic stem cell transplantation in adolescence and young adult with severe thalassemia compared to hypertransfusion and iron chelation program

... and high survival rate, is attributable to 2 key steps of RI-HSCT. First, we used rigorous criteria to select patients for RI-HSCT. We selected only patients with consistent blood transfusion and iron ...

12

Iron chelation therapy in transfusion-dependent thalassemia patients: current strategies and future directions

Iron chelation therapy in transfusion-dependent thalassemia patients: current strategies and future directions

... improving iron chelators and tailoring chelation regimens through combin- ing or alternating agents but also optimizing the treatment of the underlying disorder and, hence, decreasing the need for ...ideal ...

13

Effects of Hypoxia and Iron Chelation on the Metabolism of the Amyloid Precursor Protein in Retinal Pigmented Epithelial Cells.

Effects of Hypoxia and Iron Chelation on the Metabolism of the Amyloid Precursor Protein in Retinal Pigmented Epithelial Cells.

... Mass spectrometry was employed because of its ability to analyze protein structure in extreme detail, potentially at a resolution capable of uncovering individual glycan additions. The ultimate aim was to understand ...

156

Ceruloplasmin activity and iron chelation treatment of patients with Parkinson’s disease

Ceruloplasmin activity and iron chelation treatment of patients with Parkinson’s disease

... and iron overload measured in SN by transcranial ultrasound ...via iron accumu- lation in the SN [7], CP’s putative involvement in iron accumulation and disease progression remains subject to ...

6

Impact of treatment with iron chelation therapy in patients with lower-risk myelodysplastic syndromes participating in the European MDS registry

Impact of treatment with iron chelation therapy in patients with lower-risk myelodysplastic syndromes participating in the European MDS registry

... of iron chelation therapy in a large number of lower-risk MDS patients in daily ...in iron chelation practice across the different countries, due to variable interpretation of the poor quality ...

36

EVALUATION OF OSTEOPATHY IN PATIENTS WITH BETA THALASSEMIA MAJOR USING DIFFERENT IRON CHELATION THERAPIES

EVALUATION OF OSTEOPATHY IN PATIENTS WITH BETA THALASSEMIA MAJOR USING DIFFERENT IRON CHELATION THERAPIES

... Beta-thalassemia syndrome is a group of Hereditary Blood Disorders that are mainly characterized by the reduction or absence of beta- globin chain synthesis, resulting in a reduction of hemoglobin in red blood cells ...

5

Efficacy and safety of iron-chelation therapy with deferoxamine, deferiprone, and deferasirox for the treatment of iron-loaded patients with nontransfusion-dependent thalassemia syndromes

Efficacy and safety of iron-chelation therapy with deferoxamine, deferiprone, and deferasirox for the treatment of iron-loaded patients with nontransfusion-dependent thalassemia syndromes

... of iron-chelation therapy with deferoxamine, deferiprone, and deferasirox for the treatment of iron-loaded patients with non-transfusion-dependent thalassemia syndromes” published in January ...

6

On improvement in ejection fraction with iron chelation in thalassemia major and the risk of future heart failure

On improvement in ejection fraction with iron chelation in thalassemia major and the risk of future heart failure

... or iron-S-clusters, and in extreme condi- tions could drive cells into an apoptotic ...related iron accumulation but also iron-mediated cell ...limit iron chelation efficacy in the ...

9

Curcumin Inhibits Growth of Saccharomyces cerevisiae through Iron Chelation

Curcumin Inhibits Growth of Saccharomyces cerevisiae through Iron Chelation

... intracellular iron. Yeast cells with defects in iron homeo- stasis are sensitive to curcumin, and curcumin delays cell cycle progression in an iron-dependent ...by iron depletion of cancer ...

8

Oral iron chelation therapy with deferiprone (L1)

Oral iron chelation therapy with deferiprone (L1)

... gross iron overload, several years o f regular iron chelation are required in order to reduce the body iron burden to a safe ...the iron chelator in the serum is sufficient to ...

208

Combined Oral and Parenteral Iron Chelation in Beta Thalassaemia Major

Combined Oral and Parenteral Iron Chelation in Beta Thalassaemia Major

... Combined Oral and Parenteral Iron Chelation in Beta Thalassaemia Major ORIGINAL ARTICLE Combined Oral and Parenteral Iron Chelation in Beta Thalassaemia Maior K Balveer, MRCP*, K Pyar, FRCP*, B Wonke,[.] ...

5

Qualitative modification and development of patient- and caregiver-reported outcome measures for iron chelation therapy

Qualitative modification and development of patient- and caregiver-reported outcome measures for iron chelation therapy

... in iron overload; previously or currently on oral ICT; history of transfusion of at least 20 packed red blood cell units; able to read, write, speak, and understand English; and provide informed ...

13

Efficacy and safety of iron-chelation therapy with deferoxamine, deferiprone, and deferasirox for the treatment of iron-loaded patients with non-transfusion-dependent thalassemia syndromes

Efficacy and safety of iron-chelation therapy with deferoxamine, deferiprone, and deferasirox for the treatment of iron-loaded patients with non-transfusion-dependent thalassemia syndromes

... where iron overload is caused by chronic increase in iron absorption due to ineffective ...of iron overloading in TI is much slower in comparison to TM patients. Iron toxicity in TI is usually ...

17

Psychosocial factors influencing adherence to iron chelation therapy in patients with thalassaemia

Psychosocial factors influencing adherence to iron chelation therapy in patients with thalassaemia

... It is difficult to draw any conclusions about the incidence of non-adherence to desferal as a result of the many different definitions of non-adherence. The results do however indicate that only one quarter of the ...

165

Curcumin induces apoptosis and protective autophagy in castration-resistant prostate cancer cells through iron chelation

Curcumin induces apoptosis and protective autophagy in castration-resistant prostate cancer cells through iron chelation

... its iron-chelating ...in iron metabolism was ...induced iron deprivation in CRPC cells by chelating iron (Figure ...that iron-chelating properties contributed to apoptosis- and ...

9

Estimates of the effect on hepatic iron of oral deferiprone compared with subcutaneous desferrioxamine for treatment of iron overload in thalassemia major: a systematic review

Estimates of the effect on hepatic iron of oral deferiprone compared with subcutaneous desferrioxamine for treatment of iron overload in thalassemia major: a systematic review

... body iron burden in thalassemia major, and therefore preferred for research ...in iron chelation ...body iron than liver biopsy or SQUID because iron pools in the heart and liver may be ...

9

Abstract: Thalassemia is genetic blood disease cause by absence or decrease of one or more of

Abstract: Thalassemia is genetic blood disease cause by absence or decrease of one or more of

... of iron occur as a consequence of consistent blood ...loaded iron invokes the synthesis of reactive oxygen species that are toxic in redundancy and triggering the impairment to vascular, endocrine and ...

31

Antioxidant Studies on the Ethanolic Extract of Zornia Gibbosa

Antioxidant Studies on the Ethanolic Extract of Zornia Gibbosa

... The ethanolic extract of Zornia zibbosa, is widely used in the indigenous system of medicine was studied for its in vitro scavenging activity in different methods viz. DPPH, ABTS radical scavenging, lipid peroxidation, ...

12

Show all 7787 documents...

Related subjects